Search

everythinglearnresearchcommunity

for

Search:↓

Removing the thymoma improved the man's autoimmune conditions.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

HIV can cause unusual and severe skin problems that are hard to treat.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Certain drugs can cause lupus, stopping these drugs is the main treatment. NB-UVB phototherapy clears psoriasis faster when applied three times a week. Monoclonal antibodies and oral pimecrolimus are effective in treating psoriasis. Smoking and drinking are linked to psoriasis in men. No direct link between low iron and hair loss was found. Vaccines are effective against genital herpes and human papillomavirus type 16.

Restoring hair follicle immune privilege may help treat alopecia areata.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

Atopy and altered T cell functions contribute to Alopecia Areata.

Hidradenitis suppurativa may be a type of autoinflammatory skin disease linked to gene mutations and immune system issues.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Cyclosporine can cause a unique skin condition called "cyclosporine-induced folliculodystrophy."

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

New technologies show potential for better understanding and treating skin conditions with abnormal mucin, but more research is needed for clinical use.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Enhancing immune response can improve cancer treatment effectiveness.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Managing skin diseases during pregnancy and postpartum requires careful consideration of treatment safety and dosing to protect both mother and baby.

SII is a useful and affordable tool to assess and monitor alopecia areata.

A woman with multiple autoimmune diseases showed improvement in hair loss but not in skin discoloration after treatment.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.